FDA Tissue Arrays
Revolutionize Standards with our FDA-Adhering IHC and IVD Certified Tissue Arrays
Discover AMSBIO’s cutting edge FDA Standard Tissue Arrays, designed in alignment with the published "Guidance for Submission of Immunohistochemistry Applications" to the FDA.
Sourced from both frozen and FFPE samples our TMA’s provide the tools for advancing your research in biomarker and drug target validation. For comprehensive histological analysis, enabling researchers to study protein, RNA, or DNA molecules across diverse samples.
Key Benefits
- Designed for FDA Regulatory Compliance: aids with alignment and easier for submission to regulatory bodies
- Cost Effective: Pre-mounted and ready-to-use allowing high-throughput, low-cost analysis.
- Time Efficient: FDA tissue array formats for rapid cellular localization of RNA and protein expression.
- Quality Assured: All tissue cores verified and quality-controlled by a board-licensed pathologist.
- Guaranteed Diversity: Both normal human and animal tissue types, plus multiple tumour-type tissue arrays.
- Aids Research Standardisation and Clinical Relevance: Manufactured with samples from AMSBIO’s repository network which adheres to IRB-approved standards.
- Commercial Viabililty for High Throughput: Multiplex screening of diverse tissue types with triplicate donor samples.
Applications
- Designed to conform with FDA guidelines for tissue cross-reactivity studies.
- Antibody characterization, biomarker screening, drug discovery and target validation.
- IHC (Immunohistochemistry) and IVD (In vitro Diagnostic Devices) product certification.
- Cellular localization of tissue-specific RNA and protein expression.
Quality Control
- H.E. and immunostaining using ß-actin antibodies
- Human adult placenta tissue as a positive control and a paraffin blank as a negative control
- Identified by a board-licensed pathologist upon excision
| Name | Datasheet | Packsize | Order |
|---|---|---|---|
| FDA Standard FFPE Tissue Array |  | 1 slides | View |
| FDA Standard FFPE Tissue Array | | 5 slides | View |
| FDA Standard Frozen Tissue Array - Human Adult Normal | | 2 slides | View |
| FDA Standard Frozen Tissue Array - Human Adult Normal | | 4 slides | View |
| FDA Standard Frozen Tissue Array - Mouse Normal | | 2 slides | View |
| FDA Standard Frozen Tissue Array - Mouse Normal | | 4 slides | View |
| FDA Standard Frozen Tissue Array - Rat Normal | | 2 slides | View |
| FDA Standard Frozen Tissue Array - Rat Normal | | 4 slides | View |
Explore Precision and Efficiency with our Tissue Arrays and Panels!
Each tissue array sample undergoes meticulous examination by our board-licensed pathologists. Featuring up to 40 diverse tissues on positively charged glass slides, our arrays promise unparalleled insights. Each section enables rapid cellular localization of RNA and protein expression, making them essential tools for modern scientific inquiry.
Key Benefits
- Dual applications and detection: in situ hybridization or immunohistochemistry
- Ready-to-use and pre-mounted using high quality tissues
- Suitable for both radioactive and non-radio - active detection
- Matched RNA, DNA, cDNA protein products of each tissue on the panels available for other applications upon request
- Covers a broad range of tissues within each array
Applications
- Rapid screening of your novel gene or protein expression against an extensive panel of tissues
- Gene or protein expression pattern analysis
- Comparison of expression levels of novel genes or proteins
FFPE Cell Line Controls
AMSBIO provides a wide range of Formalin-Fixed Paraffin-Embedded (FFPE) cell line controls. Available in several formats including slides, scrolls, whole FFPE blocks, and arrays, these reference standards are an invaluable tool for immunohistochemistry (IHC), in situ hybridization, and next generation sequencing applications.
- Custom cell lines
- Lot-to-lot consistency
- Strictly controlled fixation
- Homogenous distribution
Citations
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer.
Latifa Zekri,et al. EMBO Molecular Medicine. 2020 Dec 29;13(2).
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
Prabhu VV et al. Clinical Cancer Research. 2018 Dec 17;25(7):2305–13.
Nakao H et al. Glycobiology , 2022 Nov 14, 150–64.
Khurana S. et al, Viruses. 2020 Oct 8;12(10):1140.
